|
Volumn 286, Issue 22, 2001, Pages
|
Cardiovascular events and COX-2 inhibitors.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI INFLAMMATORY AGENTS, NON STEROIDAL;
CYCLOOXYGENASE 2;
ISOENZYME;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
C REACTIVE PROTEIN;
CYCLOOXYGENASE 1;
HEART INFARCTION;
HUMAN;
NOTE;
RISK FACTOR;
CARDIOVASCULAR DISEASE;
DRUG POTENTIATION;
METABOLISM;
RISK;
THROMBOSIS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CYCLOOXYGENASE INHIBITORS;
HUMAN;
ISOENZYMES;
MYOCARDIAL INFARCTION;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE;
RISK FACTORS;
ASPIRIN;
C-REACTIVE PROTEIN;
CARDIOVASCULAR DISEASES;
DRUG SYNERGISM;
PLATELET AGGREGATION INHIBITORS;
RISK;
THROMBOSIS;
SUPPORT, NON-U.S. GOV'T;
|
EID: 0035852160
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (13)
|
References (0)
|